1-3 of 3
Miguel Romero-Cuevas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment with a novel oleic-acid–dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats

Juan M. Decara, Francisco Javier Pavón, Juan Suárez, Miguel Romero-Cuevas, Elena Baixeras, Mariam Vázquez, Patricia Rivera, Ana L. Gavito, Bruno Almeida, Jesús Joglar, Rafael de la Torre, Fernando Rodríguez de Fonseca, Antonia Serrano
Journal: Disease Models & Mechanisms
Dis Model Mech (2015) 8 (10): 1213–1225.
https://doi.org/10.1242/dmm.019919
Published: 1 October 2015
View article titled, Treatment with a novel oleic-acid–dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats
Open the PDF for Treatment with a novel oleic-acid–dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats in another window
Includes: Supplementary data
Journal Articles

Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice

Margarita Vida, Ana Luisa Gavito, Francisco Javier Pavón, Dolores Bautista, Antonia Serrano, Juan Suarez, Sergio Arrabal, Juan Decara, Miguel Romero-Cuevas, Fernando Rodríguez de Fonseca, Elena Baixeras
Journal: Disease Models & Mechanisms
Dis Model Mech (2015) 8 (7): 721–731.
https://doi.org/10.1242/dmm.019166
Published: 1 July 2015
View article titled, Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice
Open the PDF for Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice in another window
Includes: Supplementary data
Journal Articles

Elaidyl-sulfamide, an oleoylethanolamide-modelled PPARα agonist, reduces body weight gain and plasma cholesterol in rats

Juan Manuel Decara, Miguel Romero-Cuevas, Patricia Rivera, Manuel Macias-González, Margarita Vida, Francisco J. Pavón, Antonia Serrano, Carolina Cano, Nieves Fresno, Ruth Pérez-Fernández, Fernando Rodríguez de Fonseca, Juan Suárez
Journal: Disease Models & Mechanisms
Dis Model Mech (2012) 5 (5): 660–670.
https://doi.org/10.1242/dmm.009233
Published: 1 September 2012
View article titled, Elaidyl-sulfamide, an oleoylethanolamide-modelled PPARα agonist, reduces body weight gain and plasma cholesterol in rats
Open the PDF for Elaidyl-sulfamide, an oleoylethanolamide-modelled PPARα agonist, reduces body weight gain and plasma cholesterol in rats in another window
Includes: Supplementary data